| |
| |
|
| Insider
Information: |
Mainolfi Nello |
| Relationship: |
|
| City: |
Watertown |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
615,570 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
615,570 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Kymera Therapeutics, Inc. |
KYMR |
|
2024-01-02 |
615,570 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2024-01-02 |
4 |
OE |
$2.08 |
$18,720 |
D/D |
9,000 |
615,570 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2023-11-03 |
4 |
OE |
$2.08 |
$41,600 |
D/D |
20,000 |
606,570 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2023-08-08 |
4 |
OE |
$2.08 |
$24,960 |
D/D |
12,000 |
586,570 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2022-12-08 |
4 |
OE |
$2.08 |
$20,800 |
D/D |
10,000 |
573,700 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2022-10-17 |
4 |
OE |
$2.08 |
$124,243 |
D/D |
59,732 |
561,931 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2022-05-03 |
4 |
OE |
$2.08 |
$41,600 |
D/D |
20,000 |
502,199 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2022-01-14 |
4 |
OE |
$2.08 |
$20,800 |
D/D |
10,000 |
482,199 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2022-01-12 |
4 |
OE |
$2.08 |
$17,913 |
D/D |
8,612 |
480,811 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2022-01-12 |
4 |
AS |
$51.31 |
$448,551 |
D/D |
(8,612) |
472,199 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2022-01-11 |
4 |
AS |
$53.68 |
$913,795 |
D/D |
(16,923) |
472,199 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2022-01-11 |
4 |
OE |
$2.08 |
$35,200 |
D/D |
16,923 |
489,122 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2022-01-10 |
4 |
AS |
$52.46 |
$1,196,397 |
D/D |
(22,465) |
472,199 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2022-01-10 |
4 |
OE |
$2.08 |
$46,727 |
D/D |
22,465 |
494,664 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-12-16 |
4 |
OE |
$2.08 |
$16,640 |
D/D |
8,000 |
472,199 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-10-11 |
4 |
AS |
$53.58 |
$346,590 |
D/D |
(6,456) |
464,199 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-10-11 |
4 |
OE |
$2.08 |
$13,428 |
D/D |
6,456 |
470,655 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-10-08 |
4 |
OE |
$2.08 |
$86,412 |
D/D |
41,544 |
505,743 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-10-08 |
4 |
AS |
$55.56 |
$2,357,946 |
D/D |
(41,544) |
464,199 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-08-19 |
4 |
OE |
$2.08 |
$24,960 |
D/D |
12,000 |
464,199 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-08-04 |
4 |
AS |
$60.03 |
$62,253 |
D/D |
(1,037) |
452,199 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-08-04 |
4 |
OE |
$2.08 |
$2,157 |
D/D |
1,037 |
453,236 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-08-03 |
4 |
AS |
$60.07 |
$340,533 |
D/D |
(5,669) |
452,199 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-08-03 |
4 |
OE |
$2.08 |
$11,792 |
D/D |
5,669 |
457,868 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-08-02 |
4 |
OE |
$2.08 |
$48,788 |
D/D |
23,456 |
475,655 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-08-02 |
4 |
AS |
$60.21 |
$1,414,404 |
D/D |
(23,456) |
452,199 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
